312 related articles for article (PubMed ID: 16081183)
21. Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers.
Collnot EM; Baldes C; Wempe MF; Hyatt J; Navarro L; Edgar KJ; Schaefer UF; Lehr CM
J Control Release; 2006 Mar; 111(1-2):35-40. PubMed ID: 16410030
[TBL] [Abstract][Full Text] [Related]
22. iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistance.
Shen J; Meng Q; Sui H; Yin Q; Zhang Z; Yu H; Li Y
Mol Pharm; 2014 Aug; 11(8):2579-91. PubMed ID: 24236909
[TBL] [Abstract][Full Text] [Related]
23. Preparation and in vivo/in vitro evaluation of formononetin phospholipid/vitamin E TPGS micelles.
Cheng X; Yan H; Jia X; Zhang Z
J Drug Target; 2016; 24(2):161-8. PubMed ID: 26325229
[TBL] [Abstract][Full Text] [Related]
24. Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects.
Mi Y; Zhao J; Feng SS
Int J Pharm; 2012 Nov; 438(1-2):98-106. PubMed ID: 22954445
[TBL] [Abstract][Full Text] [Related]
25. Vitamin E (D-alpha-tocopheryl-co-poly(ethylene glycol) 1000 succinate) micelles-superparamagnetic iron oxide nanoparticles for enhanced thermotherapy and MRI.
Chandrasekharan P; Maity D; Yong CX; Chuang KH; Ding J; Feng SS
Biomaterials; 2011 Aug; 32(24):5663-72. PubMed ID: 21550654
[TBL] [Abstract][Full Text] [Related]
26. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer.
Mi Y; Zhao J; Feng SS
J Control Release; 2013 Aug; 169(3):185-92. PubMed ID: 23403395
[TBL] [Abstract][Full Text] [Related]
27. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
28. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles.
Pan J; Feng SS
Biomaterials; 2008 Jun; 29(17):2663-72. PubMed ID: 18396333
[TBL] [Abstract][Full Text] [Related]
29. Effect of tocopheryl polyethylene glycol succinate on the percutaneous penetration of minoxidil from water/ethanol/polyethylene glycol 400 solutions.
Sheu MT; Wu AB; Lin KP; Shen CH; Ho HO
Drug Dev Ind Pharm; 2006 Jun; 32(5):595-607. PubMed ID: 16720414
[TBL] [Abstract][Full Text] [Related]
30. Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS.
Xu P; Yin Q; Shen J; Chen L; Yu H; Zhang Z; Li Y
Int J Pharm; 2013 Sep; 454(1):21-30. PubMed ID: 23830941
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide releasing d-α-tocopheryl polyethylene glycol succinate for enhancing antitumor activity of doxorubicin.
Song Q; Tan S; Zhuang X; Guo Y; Zhao Y; Wu T; Ye Q; Si L; Zhang Z
Mol Pharm; 2014 Nov; 11(11):4118-29. PubMed ID: 25222114
[TBL] [Abstract][Full Text] [Related]
32. pH-sensitive docetaxel-loaded D-α-tocopheryl polyethylene glycol succinate-poly(β-amino ester) copolymer nanoparticles for overcoming multidrug resistance.
Zhao S; Tan S; Guo Y; Huang J; Chu M; Liu H; Zhang Z
Biomacromolecules; 2013 Aug; 14(8):2636-46. PubMed ID: 23815156
[TBL] [Abstract][Full Text] [Related]
33. TPGS-stabilized NaYbF4:Er upconversion nanoparticles for dual-modal fluorescent/CT imaging and anticancer drug delivery to overcome multi-drug resistance.
Tian G; Zheng X; Zhang X; Yin W; Yu J; Wang D; Zhang Z; Yang X; Gu Z; Zhao Y
Biomaterials; 2015 Feb; 40():107-16. PubMed ID: 25433607
[TBL] [Abstract][Full Text] [Related]
34. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release.
Zhang Z; Feng SS
Biomaterials; 2006 Jan; 27(2):262-70. PubMed ID: 16024075
[TBL] [Abstract][Full Text] [Related]
35. Docetaxel-loaded D-α-tocopheryl polyethylene glycol-1000 succinate liposomes improve lung cancer chemotherapy and reverse multidrug resistance.
Li N; Mai Y; Liu Q; Gou G; Yang J
Drug Deliv Transl Res; 2021 Feb; 11(1):131-141. PubMed ID: 32052357
[TBL] [Abstract][Full Text] [Related]
36. Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs.
Ke WT; Lin SY; Ho HO; Sheu MT
J Control Release; 2005 Feb; 102(2):489-507. PubMed ID: 15653166
[TBL] [Abstract][Full Text] [Related]
37. Combinatorial delivery of Crizotinib-Palbociclib-Sildenafil using TPGS-PLA micelles for improved cancer treatment.
de Melo-Diogo D; Gaspar VM; Costa EC; Moreira AF; Oppolzer D; Gallardo E; Correia IJ
Eur J Pharm Biopharm; 2014 Nov; 88(3):718-29. PubMed ID: 25308930
[TBL] [Abstract][Full Text] [Related]
38. Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: Therapeutic efficacy evaluation.
Huo ZJ; Wang SJ; Wang ZQ; Zuo WS; Liu P; Pang B; Liu K
Cancer Sci; 2015 Oct; 106(10):1429-37. PubMed ID: 26177628
[TBL] [Abstract][Full Text] [Related]
39. Emodin-Loaded PLGA-TPGS Nanoparticles Combined with Heparin Sodium-Loaded PLGA-TPGS Nanoparticles to Enhance Chemotherapeutic Efficacy Against Liver Cancer.
Liu H; Xu H; Zhang C; Gao M; Gao X; Ma C; Lv L; Gao D; Deng S; Wang C; Tian Y
Pharm Res; 2016 Nov; 33(11):2828-43. PubMed ID: 27511028
[TBL] [Abstract][Full Text] [Related]
40. The applications of Vitamin E TPGS in drug delivery.
Guo Y; Luo J; Tan S; Otieno BO; Zhang Z
Eur J Pharm Sci; 2013 May; 49(2):175-86. PubMed ID: 23485439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
